Toward a new understanding of attention-deficit hyperactivity disorder pathophysiology: an important role for prefrontal cortex dysfunction
- PMID: 19621976
- DOI: 10.2165/00023210-200923000-00005
Toward a new understanding of attention-deficit hyperactivity disorder pathophysiology: an important role for prefrontal cortex dysfunction
Abstract
Recent advances in neurobiology have aided our understanding of attention-deficit hyperactivity disorder (ADHD). The higher-order association cortices in the temporal and parietal lobes and prefrontal cortex (PFC) interconnect to mediate aspects of attention. The parietal association cortices are important for orienting attentional resources in time/space, while the temporal association cortices analyse visual features critical for identifying objects/places. These posterior cortices are engaged by the salience of a stimulus (its physical characteristics such as movement and colour). Conversely, the PFC is critical for regulating attention based on relevance (i.e. its meaning). The PFC is important for screening distractions, sustaining attention and shifting/dividing attention in a task-appropriate manner. The PFC is critical for regulating behaviour/emotion, especially for inhibiting inappropriate emotions, impulses and habits. The PFC is needed for allocating/planning to achieve goals and organizing behaviour/thought. These regulatory abilities are often referred to as executive functions. In humans, the right hemisphere of the PFC is important for regulating distractions, inappropriate behaviour and emotional responses. Imaging studies of patients with ADHD indicate that these regions are underactive with weakened connections to other parts of the brain. The PFC regulates attention and behaviour through networks of interconnected pyramidal cells. These networks excite each other to store goals/rules to guide actions and are highly dependent on their neurochemical environment, as small changes in the catecholamines noradrenaline (NA) or dopamine (DA) can have marked effects on PFC function. NA and DA are released in the PFC according to our arousal state; too little (during fatigue or boredom) or too much (during stress) impairs PFC function. Optimal amounts are released when we are alert/interested. The beneficial effects of NA occur at postsynaptic alpha(2A)-receptors on the dendritic spines of PFC pyramidal cells. Stimulation of these receptors initiates a series of chemical events inside the cell. These chemical signals lead to the closing of special ion channels, thus strengthening the connectivity of network inputs to the cell. Conversely, the beneficial effects of moderate amounts of DA occur at D(1) receptors, which act by weakening irrelevant inputs to the cells on another set of spines. Genetic linkage studies of ADHD suggest that these catecholamine pathways may be altered in some families with ADHD, e.g. alterations in the enzyme that synthesizes NA (DA beta-hydroxylase) are associated with weakened PFC abilities. Pharmacological studies in animals indicate catecholamine actions in the PFC are highly relevant to ADHD. Blocking NA alpha(2A)-receptors in the PFC with yohimbine produces a profile similar to ADHD: locomotor hyperactivity, impulsivity and poor working memory. Conversely, drugs that enhance alpha(2)-receptor stimulation improve PFC function. Guanfacine directly stimulates postsynaptic alpha(2A)-receptors in the PFC and improves functioning, while methylphenidate and atomoxetine increase endogenous NA and DA levels and indirectly improve PFC function via alpha(2A)- and D(1) receptor actions. Methylphenidate and atomoxetine have more potent actions in the PFC than in subcortical structures, which may explain why proper administration of stimulant medications does not lead to abuse. Further understanding of the neurobiology of attention and impulse control will allow us to better tailor treatments for specific patient needs.
Similar articles
-
The use of α-2A adrenergic agonists for the treatment of attention-deficit/hyperactivity disorder.Expert Rev Neurother. 2010 Oct;10(10):1595-605. doi: 10.1586/ern.10.133. Expert Rev Neurother. 2010. PMID: 20925474 Free PMC article. Review.
-
Neuronal mechanisms underlying attention deficit hyperactivity disorder: the influence of arousal on prefrontal cortical function.Ann N Y Acad Sci. 2008;1129:236-45. doi: 10.1196/annals.1417.007. Ann N Y Acad Sci. 2008. PMID: 18591484 Free PMC article. Review.
-
Catecholamine influences on dorsolateral prefrontal cortical networks.Biol Psychiatry. 2011 Jun 15;69(12):e89-99. doi: 10.1016/j.biopsych.2011.01.027. Epub 2011 Apr 13. Biol Psychiatry. 2011. PMID: 21489408 Free PMC article. Review.
-
Catecholamine influences on prefrontal cortical function: relevance to treatment of attention deficit/hyperactivity disorder and related disorders.Pharmacol Biochem Behav. 2011 Aug;99(2):211-6. doi: 10.1016/j.pbb.2011.01.020. Epub 2011 Feb 2. Pharmacol Biochem Behav. 2011. PMID: 21295057 Free PMC article. Review.
-
Fundamentals of attention-deficit/hyperactivity disorder: circuits and pathways.J Clin Psychiatry. 2006;67 Suppl 8:7-12. J Clin Psychiatry. 2006. PMID: 16961424 Review.
Cited by
-
Adolescence methylphenidate treatment in a rodent model of attention deficit/hyperactivity disorder: dopamine transporter function and cellular distribution in adulthood.Biochem Pharmacol. 2013 Jul 15;86(2):309-16. doi: 10.1016/j.bcp.2013.04.013. Epub 2013 Apr 23. Biochem Pharmacol. 2013. PMID: 23623751 Free PMC article.
-
A review of executive function deficits and pharmacological management in children and adolescents.J Can Acad Child Adolesc Psychiatry. 2012 Aug;21(3):223-9. J Can Acad Child Adolesc Psychiatry. 2012. PMID: 22876270 Free PMC article.
-
Understanding the effects of stimulant medications on cognition in individuals with attention-deficit hyperactivity disorder: a decade of progress.Neuropsychopharmacology. 2011 Jan;36(1):207-26. doi: 10.1038/npp.2010.160. Epub 2010 Sep 29. Neuropsychopharmacology. 2011. PMID: 20881946 Free PMC article. Review.
-
Guanfacine extended-release: in attention deficit hyperactivity disorder.Drugs. 2010 Sep 10;70(13):1693-702. doi: 10.2165/11205940-000000000-00000. Drugs. 2010. PMID: 20731476 Review.
-
Adenosine A2A Receptor Blockade Ameliorates Mania Like Symptoms in Rats: Signaling to PKC-α and Akt/GSK-3β/β-Catenin.Mol Neurobiol. 2022 Oct;59(10):6397-6410. doi: 10.1007/s12035-022-02977-2. Epub 2022 Aug 9. Mol Neurobiol. 2022. PMID: 35943710 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous